Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Israel
/
Pharmaceuticals & Biotech
Create a narrative
Can-Fite BioPharma Community
TASE:CANF Community
0
Narratives
written by author
0
Comments
on narratives written by author
1
Fair Values set
on narratives written by author
Create a narrative
Can-Fite BioPharma
Popular
Undervalued
Overvalued
Community Investing Ideas
There are no community narratives available.
Your Valuation for
CANF
CANF
Can-Fite BioPharma
Your Fair Value
₪
Current Price
₪0.01
72.4% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-15m
7m
2015
2018
2021
2024
2025
2027
2030
Revenue US$6.7m
Earnings US$1.4m
Advanced
Set Fair Value